Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats: Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate

Margaret O. James, Zimeng Yan, Rachel Cornett, V. Murali K M Jayanti, George N. Henderson, Natalia Davydova, Michael J. Katovich, Bradley H Pollock, Peter W. Stacpoole

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Pathways of metabolism of dichloroacetate (DCA), an investigational drug for the treatment of lactic acidosis in humans and a rodent hepatocarcinogen, are poorly understood. In this study, rats were given, by garage, one or two 50 mg/kg doses of NaDCA. DCA labeled with 14C (carboxy carbon) or 13C (both carbons) was used in studies of disposition and pharmacokinetics, respectively. The effect of fasting for 14 hr before dosing was studied. Expired air, urine, feces, and tissues were collected from [14C]DCA-dosed rats. Urine was analyzed by HPLC, GC/MS, and NMR spectroscopy. Plasma samples were analyzed by GC/MS. DCA plasma elimination half-lives were 0.1 ± 0.02 and 5.4 ± 0.8 hr in young adult rats (180-265 g, 3-4 months of age) given one or two doses of DCA, respectively, and 9.7 ± 1 hr in large, 16-month- old rats given two DCA doses. The percentage of the DCA dose excreted as CO2 varied from 17 to 46% and was lower (p < 0.001) in fed rats, compared with rats fasted overnight before dosing. Urine contained DCA and DCA metabolites, including oxalate, glyoxylate, and conjugated glycine (mainly hippurate and phenylacetylglycine). More unchanged DCA was excreted by large rats pretreated with DCA (mean, 20.2% of the dose) than by young adult rats given one dose of DCA (mean, 0.5%). This study confirmed that CO2, glycine, and oxalate are major products of DCA metabolism, it demonstrated that one dose of DCA altered the elimination of a subsequent dose, and it showed that age or body size, as well as access to food, significantly affected DCA metabolism in rats.

Original languageEnglish (US)
Pages (from-to)1134-1143
Number of pages10
JournalDrug Metabolism and Disposition
Volume26
Issue number11
StatePublished - Nov 1998
Externally publishedYes

Fingerprint

Pharmacokinetics
Metabolites
Metabolism
Glycine
Sprague Dawley Rats
Rats
Oxalates
Urine
Young Adult
Carbon
Investigational Drugs
Plasmas
hippuric acid
Lactic Acidosis
Investigational Therapies
Body Size
Feces
Nuclear magnetic resonance spectroscopy
Rodentia
Fasting

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats : Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate. / James, Margaret O.; Yan, Zimeng; Cornett, Rachel; Jayanti, V. Murali K M; Henderson, George N.; Davydova, Natalia; Katovich, Michael J.; Pollock, Bradley H; Stacpoole, Peter W.

In: Drug Metabolism and Disposition, Vol. 26, No. 11, 11.1998, p. 1134-1143.

Research output: Contribution to journalArticle

James, Margaret O. ; Yan, Zimeng ; Cornett, Rachel ; Jayanti, V. Murali K M ; Henderson, George N. ; Davydova, Natalia ; Katovich, Michael J. ; Pollock, Bradley H ; Stacpoole, Peter W. / Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats : Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate. In: Drug Metabolism and Disposition. 1998 ; Vol. 26, No. 11. pp. 1134-1143.
@article{d6243dec703140fc95959b56a7fac085,
title = "Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats: Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate",
abstract = "Pathways of metabolism of dichloroacetate (DCA), an investigational drug for the treatment of lactic acidosis in humans and a rodent hepatocarcinogen, are poorly understood. In this study, rats were given, by garage, one or two 50 mg/kg doses of NaDCA. DCA labeled with 14C (carboxy carbon) or 13C (both carbons) was used in studies of disposition and pharmacokinetics, respectively. The effect of fasting for 14 hr before dosing was studied. Expired air, urine, feces, and tissues were collected from [14C]DCA-dosed rats. Urine was analyzed by HPLC, GC/MS, and NMR spectroscopy. Plasma samples were analyzed by GC/MS. DCA plasma elimination half-lives were 0.1 ± 0.02 and 5.4 ± 0.8 hr in young adult rats (180-265 g, 3-4 months of age) given one or two doses of DCA, respectively, and 9.7 ± 1 hr in large, 16-month- old rats given two DCA doses. The percentage of the DCA dose excreted as CO2 varied from 17 to 46{\%} and was lower (p < 0.001) in fed rats, compared with rats fasted overnight before dosing. Urine contained DCA and DCA metabolites, including oxalate, glyoxylate, and conjugated glycine (mainly hippurate and phenylacetylglycine). More unchanged DCA was excreted by large rats pretreated with DCA (mean, 20.2{\%} of the dose) than by young adult rats given one dose of DCA (mean, 0.5{\%}). This study confirmed that CO2, glycine, and oxalate are major products of DCA metabolism, it demonstrated that one dose of DCA altered the elimination of a subsequent dose, and it showed that age or body size, as well as access to food, significantly affected DCA metabolism in rats.",
author = "James, {Margaret O.} and Zimeng Yan and Rachel Cornett and Jayanti, {V. Murali K M} and Henderson, {George N.} and Natalia Davydova and Katovich, {Michael J.} and Pollock, {Bradley H} and Stacpoole, {Peter W.}",
year = "1998",
month = "11",
language = "English (US)",
volume = "26",
pages = "1134--1143",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "11",

}

TY - JOUR

T1 - Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats

T2 - Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate

AU - James, Margaret O.

AU - Yan, Zimeng

AU - Cornett, Rachel

AU - Jayanti, V. Murali K M

AU - Henderson, George N.

AU - Davydova, Natalia

AU - Katovich, Michael J.

AU - Pollock, Bradley H

AU - Stacpoole, Peter W.

PY - 1998/11

Y1 - 1998/11

N2 - Pathways of metabolism of dichloroacetate (DCA), an investigational drug for the treatment of lactic acidosis in humans and a rodent hepatocarcinogen, are poorly understood. In this study, rats were given, by garage, one or two 50 mg/kg doses of NaDCA. DCA labeled with 14C (carboxy carbon) or 13C (both carbons) was used in studies of disposition and pharmacokinetics, respectively. The effect of fasting for 14 hr before dosing was studied. Expired air, urine, feces, and tissues were collected from [14C]DCA-dosed rats. Urine was analyzed by HPLC, GC/MS, and NMR spectroscopy. Plasma samples were analyzed by GC/MS. DCA plasma elimination half-lives were 0.1 ± 0.02 and 5.4 ± 0.8 hr in young adult rats (180-265 g, 3-4 months of age) given one or two doses of DCA, respectively, and 9.7 ± 1 hr in large, 16-month- old rats given two DCA doses. The percentage of the DCA dose excreted as CO2 varied from 17 to 46% and was lower (p < 0.001) in fed rats, compared with rats fasted overnight before dosing. Urine contained DCA and DCA metabolites, including oxalate, glyoxylate, and conjugated glycine (mainly hippurate and phenylacetylglycine). More unchanged DCA was excreted by large rats pretreated with DCA (mean, 20.2% of the dose) than by young adult rats given one dose of DCA (mean, 0.5%). This study confirmed that CO2, glycine, and oxalate are major products of DCA metabolism, it demonstrated that one dose of DCA altered the elimination of a subsequent dose, and it showed that age or body size, as well as access to food, significantly affected DCA metabolism in rats.

AB - Pathways of metabolism of dichloroacetate (DCA), an investigational drug for the treatment of lactic acidosis in humans and a rodent hepatocarcinogen, are poorly understood. In this study, rats were given, by garage, one or two 50 mg/kg doses of NaDCA. DCA labeled with 14C (carboxy carbon) or 13C (both carbons) was used in studies of disposition and pharmacokinetics, respectively. The effect of fasting for 14 hr before dosing was studied. Expired air, urine, feces, and tissues were collected from [14C]DCA-dosed rats. Urine was analyzed by HPLC, GC/MS, and NMR spectroscopy. Plasma samples were analyzed by GC/MS. DCA plasma elimination half-lives were 0.1 ± 0.02 and 5.4 ± 0.8 hr in young adult rats (180-265 g, 3-4 months of age) given one or two doses of DCA, respectively, and 9.7 ± 1 hr in large, 16-month- old rats given two DCA doses. The percentage of the DCA dose excreted as CO2 varied from 17 to 46% and was lower (p < 0.001) in fed rats, compared with rats fasted overnight before dosing. Urine contained DCA and DCA metabolites, including oxalate, glyoxylate, and conjugated glycine (mainly hippurate and phenylacetylglycine). More unchanged DCA was excreted by large rats pretreated with DCA (mean, 20.2% of the dose) than by young adult rats given one dose of DCA (mean, 0.5%). This study confirmed that CO2, glycine, and oxalate are major products of DCA metabolism, it demonstrated that one dose of DCA altered the elimination of a subsequent dose, and it showed that age or body size, as well as access to food, significantly affected DCA metabolism in rats.

UR - http://www.scopus.com/inward/record.url?scp=0031596111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031596111&partnerID=8YFLogxK

M3 - Article

C2 - 9806957

AN - SCOPUS:0031596111

VL - 26

SP - 1134

EP - 1143

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 11

ER -